Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus
about
sameAs
Phage display--a powerful technique for immunotherapy: 2. Vaccine deliveryA roadmap to generate renewable protein binders to the human proteomeRise and fall of an anti-MUC1 specific antibodyIsolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque originHuman-like antibodies neutralizing Western equine encephalitis virus.Determination of Aspergillus pathogens in agricultural products by a specific nanobody-polyclonal antibody sandwich ELISA.Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85BRecombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor.The influence of antibody fragment format on phage display based affinity maturation of IgG.Biomarkers for invasive aspergillosis: the challenges continue.Development trends for generation of single-chain antibody fragments.Generation and analysis of the improved human HAL9/10 antibody phage display libraries.Structural differences of amyloid-β fibrils revealed by antibodies from phage displayDevelopment of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype BIsolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain.Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin EProtective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine.Generation and characterization of protective antibodies to Marburg virus.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcomeDevelopment of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Phage display-derived human antibodies in clinical development and therapyA comparison of human and macaque (Macaca mulatta) immunoglobulin germline V regions and its implications for antibody engineering.Designing Human Antibodies by Phage DisplayThe European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies.Parallelized Antibody Selection in Microtiter Plates.Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail.Antibody Phage Display
P2860
Q26865013-A5B618FB-31FE-42BD-B08C-F2770EA331D3Q28237620-32889437-6615-4335-AE82-F751D203D9C7Q28743508-882B2B74-0776-4F64-9359-58A2E5A33710Q31042202-A891DC37-443D-4CCC-8274-B4C9C0DD536BQ33573599-D367D99B-1D9D-4AE5-969F-1B87BE20E0EBQ33849070-A3E9A223-9CA8-4154-B536-12772DD14151Q33994150-1B43CE6D-9C11-4792-8EB3-F36F56380D4FQ34503854-99D03118-87F5-4869-9359-9962BF4116B5Q35050036-76AC76BB-0A86-4DF4-81A8-F757243A226FQ35142428-7CE25615-C817-4D4B-865D-43B7F42AEBC8Q35216785-76C64E35-4726-4A79-A574-9FB981717AFEQ35608279-2DAD4C86-7A5E-44F9-A47A-6D9807FB98B5Q35666604-5F0B4649-B203-49DA-81F3-61641E658228Q35779652-98584287-53DA-4D6D-8EED-3EB556C1D722Q35780060-F22AC00A-5B78-42EC-9CB1-81FE6DCAA579Q36023082-5910D5FD-6B00-4945-B2CC-4425FF7CA6F9Q36126718-488261D9-297B-406B-B486-81AF37AEAB47Q36231936-41581A52-BA23-44BA-99E4-B835FA46F60EQ36305916-E1F54017-93E3-47A4-8E6E-A6C01119A151Q37287794-C3D2E637-CF1D-4336-B861-FBD296D214C6Q37698936-956FF8ED-3752-40ED-BD90-644F109DB6B2Q38508539-38828FD8-E3FE-42C3-86F3-ED72186D4CE6Q41416393-1D2625E0-BDCB-46AA-906B-58FBB4F754A0Q41894470-8883694A-608F-4DC8-BB35-0FB9DBEEC390Q42660134-5AFDDAA2-13D0-4D14-B3B4-2EE17B950473Q45235847-DFBEBB82-D2E4-498D-B12D-17CE039E1662Q50108502-6BEBE7D5-6CA6-4FFF-BBCD-CB5E930227B7Q55669069-546DC947-C40E-43C8-8C79-0EC239884AFEQ58007992-B04B68D9-A7A1-4E64-80A0-46F49DC7C11C
P2860
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus
description
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique PLoS ONE
@fr
artículu científicu espublizáu en 2009
@ast
scientific article (publication date: 13 August 2009)
@en
vedecký článok (publikovaný 2009/08/13)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/08/13)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в серпні 2009
@uk
name
Identification of a putative C ...... ction of Aspergillus fumigatus
@ast
Identification of a putative C ...... ction of Aspergillus fumigatus
@en
Identification of a putative C ...... ction of Aspergillus fumigatus
@nl
type
label
Identification of a putative C ...... ction of Aspergillus fumigatus
@ast
Identification of a putative C ...... ction of Aspergillus fumigatus
@en
Identification of a putative C ...... ction of Aspergillus fumigatus
@nl
prefLabel
Identification of a putative C ...... ction of Aspergillus fumigatus
@ast
Identification of a putative C ...... ction of Aspergillus fumigatus
@en
Identification of a putative C ...... ction of Aspergillus fumigatus
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Identification of a putative C ...... ction of Aspergillus fumigatus
@en
P2093
Dominik Hinz
Mark Schütte
Martina Inga Kirsch
Matthias Gunzer
Mike Hasenberg
Philip Rosenstock
Philippe Thullier
Ronald Frank
Thomas Schirrmann
Xenia Wezler
P2860
P3181
P356
10.1371/JOURNAL.PONE.0006625
P407
P577
2009-08-13T00:00:00Z